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A novel proliferation-sensitive and cell cycle-specific basic protein, termed progressin (Mr = 33 000), has 
been identified in proliferating human cells of epithelial, fibroblast and lymphoid origin. Progressin is syn- 
thesized almost exclusively during the S-phase of transformed human amnion cells (AMA). Increased syn- 
thesis of this protein is first detected late in G,, at or near the G,/S transition border, reaches a maximum 
in mid to late S-phase, and declines thereafter. Contrary to histones, progressin synthesis is not coupled 
to DNA replication. As expected for an S-phase-specific protein, no detectable synthesis of progressin was 
observed in non-proliferating human MRC-5 fibroblasts and epidermal basal keratinocytes. Elevated, but 
variable levels of this protein were observed in proliferating normal fibroblasts and transformed cells of 
fibroblast, epithelial and lymphoid origin. Taken together the above observations suggest hat progressin 
may be a component of the common pathway leading to DNA replication and cell division. 
Cell proliferation; Cell cycle; Initiation of DNA replication; Transformation; Cancer 
1. INTRODUCTION 
Understanding of the molecular mechanisms 
underlying malignant transformation and cancer 
will ultimately require unraveling of the pathways 
that control cell proliferation in normal cells. In 
this laboratory we have focused our research on 
the identification of proteins that are putative 
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components of the common pathway leading to 
DNA replication and cell division in human cells 
([1,2] and references therein). These proteins are 
expected (i) to be common to all cell types and (ii) 
to be synthesized in a cell cycle specific fashion: in- 
creased synthesis tarting late in Gr, near the Gr/S 
transition border. So far, two proteins have been 
identified that exhibit these characteristics. These 
correspond to the DNA replication protein cyclin 
[l-5], also termed PCNA [6-81 or auxiliary protein 
of DNA polymerase 6 [9-l 11, and the nuclear 
phosphoprotein dividin [ 12,131. Here we describe a 
novel proliferation-sensitive and cell cycle-specific 
human basic protein that we have termed pro- 
gressin (M = 33 000, fig.1). The role of pro- 
gressin, cyclin (PCNA) and dividin in cell cycle 
progression is discussed. 
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2. MATERIALS AND METHODS 
2.1. Cells 
All the cells used in this study were grown in 
Dulbecco’s modified Eagle’s medium (DMEM) 
containing 10% (v/v) fetal calf serum and an- 
tibiotics (penicillin at 100 U/ml, steptomycin at 50 
pg/ml). Human epidermal basal keratinocytes 
were prepared as described [14]. The 
SV40-transformed human keratinocytes (SVK14) 
[15] were kindly provided by E.B. Lane (Imperial 
Cancer Research Laboratories, London). 
2.2. Cell cycle studies, 
Mitotic AMA cells were obtained by mechanical 
detachment essentially as described by Terasima 
and Tolmach [16]. Two 250-m] flasks containing 
l-2 x lo6 cells per flask were used. The 
homogeneity of the collected cells was assessed by 
phase-contrast microscopy. Cells for [35S]methio- 
nine labeling were plated in microtiter wells 
(96-well plates, Nunc), while those for immuno- 
fluorescence were plated in round glass coverslips. 
Entrance of the cells into S-phase was determined 
by indirect immunofluorescence using PCNA anti- 
bodies specific for cyclin [6,17] (a kind gift of 
E. Tan). 
2.3. Quiescent cultures 
MRC-5 human fibroblasts were trypsinized and 
plated (microtiter wells or glass coverslips) in 
DMEM containing 10% (v/v) fetal bovine serum. 
One day later, the medium was changed to DMEM 
plus 0.5% serum. The cultures were then left for 4 
days in the same medium. Cells were released by 
adding DMEM containing 10% (v/v) serum. 
2.4. [-“SJMethionine labeling 
Synchronous interphase cells grown in 
microtiter wells (96-well plates, Nunc) were labeled 
for 30 min with 1 mCi [35S]methionine per ml as 
described [18,191. At the end of the labeling period 
the medium was aspirated, and the cells were 
resuspended in 20 ~1 lysis buffer [20]. Mitotic cells 
(in suspension) were labeled for 30 min under 
similar conditions. 
2.5. Two-dimensional gel electrophoresis 
2D gel electrophoresis (NEPGHE) was carried 
out as described [21,22]. In short, the first dimen- 
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sion was performed in 130 mm x 1.2 mm, 4% 
(w/v) polyacrylamide gels containing 5% ampho- 
lines (3% pH 7-9 (LKB); 2% pH 8-9.5 (LKB); 
4.5 h at 400 V). Gels were processed for fluoro- 
graphy as described by Laskey and Mills [23]. 
2.6. Indirect immunojluorescence 
Cells grown in round glass coverslips (12 mm in 
diameter) were washed three times with Hanks’ 
saline solution and treated for 5 min at -20°C 
with methanol. After washing extensively with 
Hanks’ saline solution, the coverslips were covered 
with 20 ~1 of anticyclin (PCNA) antibodies (I:200 
dilution) and incubated for 60 min at 37°C in a 
humid environment. The coverslips were then 
washed several times with Hanks’ saline solution 
and covered with 20 ~1 of rhodamine-conjugated 
goat antihuman IgG (diluted 1: 150 in Hanks’ 
saline dilution). After 60 min of incubation at 
37°C in a humid environment, the coverslips were 
washed thoroughly with Hanks’ saline solution 
and were mounted in Gelvatol. Observations were 
made on a Zeiss photomicroscope quipped with 
epifluorescence and phase contrast optics. 
3. RESULTS 
3.1. Increased synthesis of progressin in pro- 
liferating human cells of fibroblast, epithelial 
and lymphoid origin 
Fig.2A and B shows the appropriate areas of 
NEPHGE 2D gels of [35S]methionine-labeled pro- 
teins from slowly proliferating MRC-5 fibroblasts 
(~38, fig.2A) and their SV40 transformed counter- 
parts (MRC-5 V2, fig.2B). Similar gels of non- 
proliferating human epidermal basal keratinocytes 
and SV40 transformed keratinocytes (K14) are 
shown in fig.2C and D, respectively. As seen in 
Fig.2A and C, low levels of synthesis of progressin 
were observed in the slowly proliferating fibro- 
blasts (fig.2A), while little of this protein was 
detected in the non-proliferating basal cells 
(fig.2C). Low levels of synthesis of progressin have 
also been observed in normal human lymphocytes 
(not shown). Of the so far studied transformed 
human cell types, those that exhibit high levels of 
progressin synthesis include: W138 SV40, Hela 
(fig.2E), Detroit-98, Chang Liver, Fl-amnion, 
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Fig.1. Position of progressin in 2D gels (NEPHGE) of 
[35S]methionine-labeled proteins from AMA cells. The 
position of elongation factor EF-la and dividin are in- 
dicated for reference. 
A431 and Molt-4 (fig.2F). Polypeptides having the 
same coordinates (W and pr) as progressin have 
not been observed in proliferating mouse cells. 
3.2. Progressin in synthesized preferentially during 
the S-phase of the cell cycle of transformed 
human amnion cells (AMA) 
Mitotic AMA cells obtained by gently 
mechanical shake off as well as synchronized inter- 
phase cells were labeled for 30 min at 37°C with 
[35S]methionine and the radioactive proteins were 
analyzed by NEPHGE 2D-gel electrophoresis 
[21,22]. Representative gels of labeled proteins 
from mitotic, Gr (labeled 2, 5 and 9 h after plating 
mitotic cells), S (labeled 12 and 15 h after plating 
mitotic cells) and G2 cells (labeled 20.5 h after 
plating mitotic cells) are shown in fig.3B. The 
duration of the cell cycle phases (sub-S-phases in- 
cluded, fig.3A; see [25]), patterns of cyclin 
(PCNA) antigen distribution (fig.3D) and levels of 
dividin (fig.3C) are also shown in fig.3. Increased 
synthesis of progressin is first detected late in Gi 
near the Gi/S transition border, reaches a max- 
- NEPHGE -NEPHGE ‘ 
Fig.2. Synthesis of progressin in normal and transform- 
ed human cells. Cells were labeled for 2 h with 
[3sS]methionine as described in section 2. (A) Human 
MRCJ fibroblasts (~38); (B) SV40 transformed MRCJ 
(MRC-5 V2); (C) non-proliferating human epidermal 
basal keratinocytes (kept in DMEM with high Ca’ + con- 
centration); (D) SV40 transformed keratinocytes (SV14); 
(E) HeLa; (F) Molt-4; (G) quiescent human MRC-5 
fibroblasts; and (H) MRCJ fibroblasts labeled 19 h 
after release. Only the appropriate region of the gels are 
shown. 
imum in mid to late S-phase, and declines 
thereafter (fig.3B). Low levels of synthesis of pro- 
gressin were detected in mitotic, Gi and G2 
(fig.3B). Increased rate of synthesis of progressin 
has also been observed in growth-arrested MRC-5 
fibroblasts (kept for 96 h in DMEM containing 
0.5% serum) stimulated to enter S-phase by addi- 
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Fig.3. Synthesis of [%]methionine-labeled progressin throughout the cell cycle of AMA cells. (A) Duration of the cell 
cycle phases (duration of sub-S-phases is also included; see [25]). (B,C) synthesis of progressin (B) and dividin (C) at 
various stages of the cell cycle. Cells were labeled for 30 min as described in section 2. Gt cells were labeled 2.5, and 
9 h after plating mitotic cells. S-phase cells were labeled 12 and 15 h after plating, while GZ cells were labeled 20.5 h 
later. (D) Patterns of cyclin (PCNA) antigen distribution as determined by indirect immunofluorescence of methanol- 
fixed cells. Areas of the gels shown in this figure are enclosed in fig.1. 
V NEPHGE -NEPHGE 
Fig.4. Progressin synthesis and cyclin (PCNA) antigen 
distribution in synchronized AMA cells treated with 
thymidine. Gr AMA cells were treated with thymidine (2 
mM final concentratgion; added 1 h after plating mitotic 
cells) and labeled with [“Slmethionine for 30 min, 14 h 
after its addition. (A) Control untreated cells; (B) 
thymidine-treated cells; (C) patterns of cyclin (PCNA) 
antigen distribution in control; and (D) patterns of 
cyclin (PCNA) antigen distribution in thymidine-treated 
cells. 
tion of DMEM containing 10% serum (fig.2H). 
No detectable levels of progressin were observed in 
the growth-arrested cells (fig.2G). 
3.3. Progressin synthesis is not coupled to DNA 
replication 
To determine if progressin synthesis was depen- 
dent on DNA replication we added thymidine (2 
mM final concentration) to synchronized Gi cells 
(1 h after plating mitotic cells) and analyzed the 
[3sS]methionine-labeled proteins synthesized dur- 
ing a 30 min period, 14 h after its addition (S- 
phase, see also fig.3A). As shown in fig.4, similar 
levels of progressin were observed in the 
thymidine-treated cells (fig.4B) as compared to the 
untreated control cells (fig.4A). Indirect im- 
munofluorescence analysis of methanol-fixed cells 
confirmed that the thymidine-treated cells were 
blocked at the Gl/S transition border of the cell cy- 
cle (fig.3D). Untreated cells on the other hand pro- 
gressed into S-phase as judged by the late patterns 
of cyclin (PCNA) antigen distribution (fig.4C) 
[17,24,26]. 
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4. DISCUSSION 
Identification of proteins that may be com- 
ponents of the common pathway leading to DNA 
replication and cell division may be instrumental in 
understanding the mechanisms that control cell cy- 
cle progression and proliferation. So far, we have 
identified three proliferation-sensitive and cell 
cycle-specific proteins that are likely components 
of this pathway. In addition to progressin, these 
include the DNA replication protein cyclin 
(PCNA) [4-9,25,27-291 and the nuclear 
phosphoprotein dividin [ 12,131. In contrast to 
histones, the synthesis of progressin, cyclin 
(PCNA) and dividin is independent of DNA 
replication ([26]; this article). In vivo replicative 
DNA synthesis on the other hand has not been 
observed in the absence of synthesis of these 
proteins. 
What is the role of progressin, cyclin (PCNA) 
and dividin in the initiation of DNA replication 
and cell cycle progression in human cells? Our 
studies concerning distribution of cyclin (PCNA) 
and DNA replication in binucleated homokaryons 
produced by polyethylene glycol (PEG)-induced 
fusion of mitotic AMA cells have shed some light 
onto this question [25]. A small percentage of 
asynchronous S-phase homokaryons were ob- 
served in these fusions suggesting that (an) in- 
Fig.5. Some events at the G/S transition border of the 
cell cycle of human AMA cells. Increased synthesis of 
histones, ODC (ornithine decarboxylase), TK 
(thymidine kinase), DHFR (dihydrofolate reductase), c- 
myb, ~55 and TS (thymidine synthetase), during S-phase 
has been observed in various cell types ([32] and 
references therein), but has not been investigated in 
AMA cells. The synthesis of histones and ODC is depen- 
dent on DNA replication while synthesis of cyclin 
(PCNA), dividin, progressin, TK and DHFR is unaf- 
fected by inhibitors of DNA replication (126,321 and 
references therein; this article). 
tranuclear event(s) was (were) required for cyclin 
(PCNA) distribution and DNA replication ir- 
respective of the fact that these nuclei shared com- 
mon cytoplasmic factors [25,30] (fig.5). The 
nature of this (these) intranuclear event(s) is at pre- 
sent unknown, although it may correspond to the 
formation of pre-replicative complexes. Here, we 
would like to propose that newly synthesized S- 
phase cyclin (PCNA) (and perhaps progressin and 
dividin) may be one of the factors that trigger in- 
itiation of DNA replication once pre-replicative 
complexes are formed. 
Taken together, our studies also imply that, 
most likely, cell cycle progression is not controlled 
by a single labile protein as suggested by Rossov et 
al. [31], but rather by a set of events (a few are in- 
dicated in fig.5; see [32]), some of which seem to 
be independent of each other [33]. 
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